Position in BMRN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$145,911
-$6,612 QoQ
Shares Held
2,550
-5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#431
of 561 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SITTNER & NELSON, LLC holds $972,877 across 13 Biotechnology names. BMRN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
615 | $305,488 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
4,801 | $261,846 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
2,550 | $145,911 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,449 | $113,413 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
95 | $59,236 | |
| 6 | MRNA |
Moderna, Inc.
|
650 | $45,519 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
75 | $14,046 | |
| 8 | BNTX |
BioNTech SE
|
100 | $9,305 |
All Filings in BMRN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,911 | 2,550 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $152,523 | 2,700 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $160,461 | 2,700 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $151,648 | 2,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $170,407 | 3,100 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $205,001 | 2,900 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $190,617 | 2,900 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $203,841 | 2,900 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $246,990 | 3,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $262,020 | 3,000 | Shares | Sole | 2024-05-10 | |
| 2023-06-30 | $3,900 | 45 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||